Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
August 4, 2015
0Patent Application Number
123963130
Date Filed
March 2, 2009
0Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention relates to novel antibodies, particularly antibodies directed against deletion mutants of epidermal growth factor receptor and particularly to the type III deletion mutant, EGFRvIII. The invention also relates to human monoclonal antibodies directed against deletion mutants of epidermal growth factor receptor and particularly to EGFRvIII. Diagnostic and therapeutic formulations of such antibodies, and immunoconjugates thereof, are also provided.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
